CellFree Sciences cfsciences.com


Public lists: Pharma Startups (4743)

ENDEXT Technology signifies the wheat germ cell-free protein synthesis technology that was developed by Professor Yaeta Endo of Ehime University. The wheat germ lysate produced by the technology is free of translation inhibitors, and as a result, it permits remarkably stable in vitro protein synthesis: all that is needed for the synthesis is to add the target mRNA as well as the amino acids and other substrates to the lysate. The eukaryotic origin of the ENDEXT(R) wheat germ lysate has made it p...Show all

ENDEXT Technology signifies the wheat germ cell-free protein synthesis technology that was developed by Professor Yaeta Endo of Ehime University. The wheat germ lysate produced by the technology is free of translation inhibitors, and as a result, it ...Show all

Company (Alive / Active)

Phone: (+8) 189-925-1088

Fax: (+8) 189-925-1099

3 Bunkyo-cho,Ehime Univ.Venture Bus Lab
4F
790-8577
Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CellFree Sciences $0M Apr 19, 2019
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CellFree Sciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Gyros

Uppsala, Sweden
MergedGyros is a provider of automated micro-immunoassays for therapeutic protein development. The company offers Gyrolab(R), an analytical tool that aims to reduce the time required to optimize and execute immunoassays. Per the company, Gyrolab allows assays to be conducted with a significantly reduced background, increased dynamic range and with higher throughput.Login to see details

GlycoFi

Lebanon, New Hampshire, United States
AcquiredGlycoFi, Inc. was founded in 2000 with the mission of dramatically improving the capacity and cost of producing human therapeutic proteins, while simultaneously enhancing their efficacy and safety as therapeutics. The company harnesses the inherent advantages of yeast and other fungal-based protein expression systems by engineering these systems to produce correctly glycosylated human therapeutic proteins, thus greatly increasing the efficiency, fidelity and scalability at which those proteins c...Show allLogin to see details
See all 17 competitors